ArticleCancers2021

PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System.

Anouk Corbeau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.